Nyxoid 1
Nyxoid 1 is a medicine authorised by Swissmedic under authorisation number 66930. The authorisation holder is Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 July 2018 and the authorisation is valid without a time limit. ATC code V03AB15 places the medicine in the group All other therapeutic products.
| Authorisation number | 66930 |
|---|---|
| Name | Nyxoid 1 |
| Full name | Nyxoid 1,8 mg, Nasenspray |
| Authorisation holder | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | V03AB15 |
| First authorisation | 12 July 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Nyxoid 1,8 mg, Nasenspray | B | 12 July 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 | Einzeldose(n) | V03AB15 | 15.01.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Nyxoid 1 authorised in Switzerland?
Yes. Nyxoid 1 is authorised by Swissmedic under authorisation number 66930, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Nyxoid 1 have?
Nyxoid 1 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Nyxoid 1?
The authorisation holder is Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.